FDA: Gardasil may help prevent vaginal and vulvar cancer
The FDA recently released a report indicating that the human papillomavirus (HPV) vaccine, Gardasil, may also help prevent vaginal and vulvar cancer in girls and women between the ages of nine and 26. The ruling was in response to a two-year follow-up study by Merck, Gardasil’s manufacturer. The study indicated that the drug was “highly-effective” in preventing precancerous vulvar and vaginal lesions in women who tested negative for HPV.
Along with these findings, Merck has also revised the label to indicate that the vaccine is not effective in women over the age of 26.
The FDA approved Gardasil in 2006 for the prevention of cervical cancer and precancerous lesions caused by HPV types 6, 11, 16 and 18. Gardasil is also approved for the prevention of genital warts caused by types 6 and 11.
Bookmark this page
E-mail this story
Print this post
0 Responses to “FDA: Gardasil may help prevent vaginal and vulvar cancer”